Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

73.7K
Overview
73.7K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

7.0K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
7.0K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

4.7K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

2.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.4K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

506
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
506

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inherent tissue homeostasis of the juvenile metaphysis provides a foundation for osteosarcoma development.

Nature communications·2026
Same author

Self-reinforcing IL-1β signaling accelerates the development and recurrence of TCF3::HLF-positive B-ALL.

Blood·2026
Same author

Hypoxia drives progression of multiple sclerosis by enhancing the inflammasome activation in macrophages with Porphyromonas gingivalis infection.

Cell death discovery·2025
Same author

Fam102a translocates Runx2 and Rbpjl to facilitate Osterix expression and bone formation.

Nature communications·2025
Same author

RANK drives structured intestinal epithelial expansion during pregnancy.

Nature·2024
Same author

Correction: Crosstalk between bone and the immune system.

Journal of bone and mineral metabolism·2024

Related Experiment Video

Updated: Sep 17, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

542

Bone Voyage: OPN's Path from Skeleton to Systemic Immunosuppression.

Kyoko Hashimoto1, Kazuo Okamoto2,3, Hiroshi Takayanagi1

  • 1Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.

Cancer Research
|June 30, 2025
PubMed
Summary

Bone metastases suppress anti-cancer immunity and hinder immune checkpoint blockade (ICB) therapy. Targeting osteoclasts and osteopontin (OPN) can restore T-cell function and improve ICB treatment effectiveness.

More Related Videos

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

14.7K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.9K

Related Experiment Videos

Last Updated: Sep 17, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

542
A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

14.7K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.9K

Area of Science:

  • Immunology
  • Oncology
  • Osteoimmunology

Background:

  • Immune checkpoint blockade (ICB) therapy has transformed cancer treatment but faces resistance.
  • Mechanisms of resistance, particularly in the context of bone metastases, require further elucidation.

Purpose of the Study:

  • To investigate how bone metastases impact systemic antitumor immunity and ICB response.
  • To identify molecular mechanisms by which bone microenvironment affects T-cell function and ICB efficacy.

Main Methods:

  • Analysis of clinical patient cohorts with bone metastases.
  • Mechanistic studies involving osteoclast-derived osteopontin (OPN) and T-cell differentiation.
  • Preclinical cancer models evaluating therapeutic interventions targeting osteoclasts.

Main Results:

  • Patients with bone metastases showed reduced responsiveness to ICB.
  • Bone metastases promote osteopontin (OPN) production by osteoclasts, which impairs T-cell differentiation.
  • Targeting osteoclasts or OPN in preclinical models restored T-cell function and improved ICB efficacy.

Conclusions:

  • Bone metastases actively suppress systemic antitumor immunity, contributing to ICB resistance.
  • Osteopontin (OPN) secreted by osteoclasts mediates immunosuppression beyond the bone microenvironment.
  • Targeting the osteoimmune axis presents a promising strategy to overcome ICB resistance in patients with bone metastases.